Skip to main content

Table 1 Clinical characteristics of the studied population

From: Genetic and clinical study of myeloperoxidase's association with coronary artery disease

Variables

CAD (n = 70)

Control (n = 30)

P-value

Age (Years)

58.8 ± 9.9

51.6 ± 10.8

0.0036*

Age range

41–85

33–75

–

Renal function tests

urea (mg/dL)

36.6 ± 17.4

30.8 ± 10.1

0.1113

Creatinine (mg/dL)

1.9 ± 7.9

0.8 ± 0.3

0.0062*

Liver function tests

GPT (U/L)

12.4 ± 8

9.7 ± 4.8

0.1500

GOT (U/L)

25.5 ± 22.9

20.4 ± 10

0.1823

Total Bilirubin (mg/dL)

0.5 ± 0.3

0.4 ± 0.2

0.0090*

Alp (U/L)

78.5 ± 21.9

72.5 ± 24

0.0405*

LDH (U/L)

235 ± 185.3

198.6 ± 124.9

0.4205

Lipid profile and lipid ratios

Cholesterol (mg/dL)

154.5 ± 42.5

156.9 ± 37.9

0.8268

TG (mg/dL)

172.2 ± 98.6

190.5 ± 81.8

0.2648

HDL (mg/dL)

36.3 ± 7.8

38.1 ± 12.6

0.9806

LDL (mg/dL)

86.5 ± 38.7

80.3 ± 32.3

0.5282

TG/HDL-C ratio

5.3 ± 4.4

5.7 ± 3.5

0.3619

LDL-C/HDL-C ratio

2.5 ± 1.4

2.2 ± 0.9

0.6711

Cardiac function tests

CRP (mg/L)

22.7 ± 65.3

6.5 ± 9.6

0.2001

CKmB (U/L)

25.1 ± 41.3

18.7 ± 25.3

0.2729

Troponin (ng/mL)

1.5 ± 4.7

0.1 ± 0.01

0.0042*

Glucose (mg/dL)

154 ± 77.6

110.1 ± 46.5

0.0042*

  1. Results are expressed as numbers or means ± SD. *Statistical significance